Xeroderma pigmentosum group B
XPB

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 9 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Sun sensitivity integumentary 100 % 16947863 2015-08-12
Decreased recovery of RNA synthesis after DNA damage multi 100 % 16947863 2015-08-12
Cellular UV sensitivity multi 100 % 16947863 2015-08-12
Skin pigmentation changes integumentary 78 % 16947863 2015-08-12
Hearing loss nervous 78 % 16947863 2015-08-12
Retinitis pigmentosa nervous 67 % 16947863 2015-08-12
Short stature multi 56 % 16947863 2015-08-12
Hypogonadism endocrine 50 % 16947863 2015-08-12
Cancer integumentary 44 % 16947863 2015-08-12
Cataract nervous 33 % 16947863 2015-08-12
Hyperactive reflexes nervous 33 % 16947863 2015-08-12
Developmental delay nervous 33 % 16947863 2015-08-12
Optic atrophy nervous 22 % 16947863 2015-08-12
Hypermetropia nervous 22 % 16947863 2015-08-12
Microcephaly nervous 13 % 16947863 2015-08-12
Areflexia nervous 11 % 16947863 2015-08-12



List of references:


Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Kyu-Seon Oh, Sikandar G Khan, N G J Jaspers, Anja Raams, Takahiro Ueda, Alan Lehmann, Peter S Friedmann, Steffen Emmert, Alexi Gratchev, Katherine Lachlan, Anneke Lucassan, Carl C Baker, Kenneth H Kraemer,



Human mutation - Nov 2006